← Evidence map

ReviewDrug safety2014

Benefit-risk assessment of orlistat in the treatment of obesity.

Priya Sumithran et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

19 papers cite it

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25064699